Satellos Bioscience Inc. (TSX:MSCL)
Canada
· Delayed Price · Currency is CAD 10.41
+0.57 (5.79%)
Apr 28, 2026, 3:59 PM EST
Satellos Bioscience Market Cap
Satellos Bioscience has a market cap or net worth of CAD 216.85 million as of April 28, 2026. Its market cap has increased by 107.57% in one year.
Market Cap
216.85M
Enterprise Value
178.86M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
10.41
Market Cap Chart
Since August 19, 2021, Satellos Bioscience's market cap has increased from 58.83M to 216.85M, an increase of 268.60%. That is a compound annual growth rate of 32.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 216.85M | 77.12% |
| Dec 31, 2025 | 122.43M | -11.04% |
| Dec 31, 2024 | 137.63M | 183.77% |
| Dec 29, 2023 | 48.50M | 427.44% |
| Dec 30, 2022 | 9.20M | -72.13% |
| Dec 31, 2021 | 33.00M | -43.91% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Helix BioPharma | 144.35M |
| ME Therapeutics Holdings | 75.12M |
| Eupraxia Pharmaceuticals | 607.04M |
| Sharp Therapeutics | 63.16M |
| Sernova Biotherapeutics | 61.45M |
| NurExone Biologic | 56.15M |
| Medicenna Therapeutics | 50.89M |
| MedMira | 42.10M |